MORGAN STANLEY - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$265,000
-13.4%
125,946
+18.9%
0.00%
Q1 2021$306,000
-77.1%
105,884
-83.1%
0.00%
Q4 2020$1,337,000
+11041.7%
624,813
+32612.7%
0.00%
Q3 2020$12,000
-81.8%
1,910
-81.3%
0.00%
Q2 2020$66,000
+73.7%
10,216
+58.6%
0.00%
Q4 2019$38,000
+81.0%
6,442
+68.1%
0.00%
Q3 2019$21,0003,8320.00%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q3 2021.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders